335 related articles for article (PubMed ID: 37122746)
1. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.
Renner TM; Akache B; Stuible M; Rohani N; Cepero-Donates Y; Deschatelets L; Dudani R; Harrison BA; Baardsnes J; Koyuturk I; Hill JJ; Hemraz UD; Régnier S; Lenferink AEG; Durocher Y; McCluskie MJ
Front Immunol; 2023; 14():1182556. PubMed ID: 37122746
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.
Akache B; Renner TM; Tran A; Deschatelets L; Dudani R; Harrison BA; Duque D; Haukenfrers J; Rossotti MA; Gaudreault F; Hemraz UD; Lam E; Régnier S; Chen W; Gervais C; Stuible M; Krishnan L; Durocher Y; McCluskie MJ
Sci Rep; 2021 Nov; 11(1):21849. PubMed ID: 34750472
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.
Akache B; Jia Y; Chandan V; Deschatelets L; McCluskie MJ
Methods Mol Biol; 2022; 2412():255-267. PubMed ID: 34918249
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.
Agbayani G; Akache B; Renner TM; Tran A; Stuible M; Dudani R; Harrison BA; Duque D; Bavananthasivam J; Deschatelets L; Hemraz UD; Régnier S; Durocher Y; McCluskie MJ
Eur J Immunol; 2024 Jun; 54(6):e2350620. PubMed ID: 38561974
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.
Stark FC; Akache B; Deschatelets L; Tran A; Stuible M; Durocher Y; McCluskie MJ; Agbayani G; Dudani R; Harrison BA; Renner TM; Makinen SR; Bavananthasivam J; Duque D; Gagne M; Zimmermann J; Zarley CD; Cochrane TR; Handfield M
Sci Rep; 2022 Jun; 12(1):9772. PubMed ID: 35697917
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
7. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
McCluskie MJ; Deschatelets L; Krishnan L
Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
[TBL] [Abstract][Full Text] [Related]
9. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
10. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
[TBL] [Abstract][Full Text] [Related]
11. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
[TBL] [Abstract][Full Text] [Related]
12. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine.
Deliyannis G; Gherardin NA; Wong CY; Grimley SL; Cooney JP; Redmond SJ; Ellenberg P; Davidson KC; Mordant FL; Smith T; Gillard M; Lopez E; McAuley J; Tan CW; Wang JJ; Zeng W; Littlejohn M; Zhou R; Fuk-Woo Chan J; Chen ZW; Hartwig AE; Bowen R; Mackenzie JM; Vincan E; Torresi J; Kedzierska K; Pouton CW; Gordon TP; Wang LF; Kent SJ; Wheatley AK; Lewin SR; Subbarao K; Chung AW; Pellegrini M; Munro T; Nolan T; Rockman S; Jackson DC; Purcell DFJ; Godfrey DI
EBioMedicine; 2023 Jun; 92():104574. PubMed ID: 37148585
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits.
O'Kennedy MM; Abolnik C; Smith T; Motlou T; Goosen K; Sepotokele KM; Roth R; du Preez I; Truyts A; Stark HC; Magwaza M; Mahanjana O; Verschoor JA; Moore PL; Lemmer Y
Vaccine; 2023 Mar; 41(13):2261-2269. PubMed ID: 36868876
[TBL] [Abstract][Full Text] [Related]
14. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Arunachalam PS; Walls AC; Golden N; Atyeo C; Fischinger S; Li C; Aye P; Navarro MJ; Lai L; Edara VV; Röltgen K; Rogers K; Shirreff L; Ferrell DE; Wrenn S; Pettie D; Kraft JC; Miranda MC; Kepl E; Sydeman C; Brunette N; Murphy M; Fiala B; Carter L; White AG; Trisal M; Hsieh CL; Russell-Lodrigue K; Monjure C; Dufour J; Spencer S; Doyle-Meyers L; Bohm RP; Maness NJ; Roy C; Plante JA; Plante KS; Zhu A; Gorman MJ; Shin S; Shen X; Fontenot J; Gupta S; O'Hagan DT; Van Der Most R; Rappuoli R; Coffman RL; Novack D; McLellan JS; Subramaniam S; Montefiori D; Boyd SD; Flynn JL; Alter G; Villinger F; Kleanthous H; Rappaport J; Suthar MS; King NP; Veesler D; Pulendran B
Nature; 2021 Jun; 594(7862):253-258. PubMed ID: 33873199
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity.
Liao HC; Wu WL; Chiang CY; Huang MS; Shen KY; Huang YL; Wu SC; Liao CL; Chen HW; Liu SJ
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563292
[TBL] [Abstract][Full Text] [Related]
16. Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
Liu H; Zhou C; An J; Song Y; Yu P; Li J; Gu C; Hu D; Jiang Y; Zhang L; Huang C; Zhang C; Yang Y; Zhu Q; Wang D; Liu Y; Miao C; Cao X; Ding L; Zhu Y; Zhu H; Bao L; Zhou L; Yan H; Fan J; Xu J; Hu Z; Xie Y; Liu J; Liu G
Vaccine; 2021 Nov; 39(48):7001-7011. PubMed ID: 34750014
[TBL] [Abstract][Full Text] [Related]
17. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
Jia Y; Chandan V; Akache B; Qian H; Jakubek ZJ; Vinogradov E; Dudani R; Harrison BA; Jamshidi MP; Stark FC; Deschatelets L; Sauvageau J; Williams D; Krishnan L; McCluskie MJ
J Liposome Res; 2021 Sep; 31(3):237-245. PubMed ID: 32583693
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
19. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
Chiba S; Halfmann PJ; Iida S; Hirata Y; Sato Y; Kuroda M; Armbrust T; Spyra S; Suzuki T; Kawaoka Y
Vaccine; 2023 Sep; 41(41):6025-6035. PubMed ID: 37635002
[TBL] [Abstract][Full Text] [Related]
20. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
Akache B; Agbayani G; Stark FC; Jia Y; Dudani R; Harrison BA; Deschatelets L; Chandan V; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]